RILEY EXPLORATION PERMIAN IN (REPX) Fundamental Analysis & Valuation

NYSEARCA:REPX • US76665T1025

Current stock price

37.17 USD
-0.28 (-0.75%)
At close:
37.17 USD
0 (0%)
After Hours:

This REPX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. REPX Profitability Analysis

1.1 Basic Checks

  • In the past year REPX was profitable.
  • REPX had a positive operating cash flow in the past year.
  • REPX had positive earnings in 4 of the past 5 years.
  • In the past 5 years REPX always reported a positive cash flow from operatings.
REPX Yearly Net Income VS EBIT VS OCF VS FCFREPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 13.75%, REPX belongs to the top of the industry, outperforming 93.30% of the companies in the same industry.
  • REPX has a Return On Equity of 25.36%. This is amongst the best in the industry. REPX outperforms 89.95% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 10.67%, REPX belongs to the top of the industry, outperforming 85.65% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for REPX is significantly below the industry average of 23.05%.
  • The 3 year average ROIC (14.93%) for REPX is well above the current ROIC(10.67%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 13.75%
ROE 25.36%
ROIC 10.67%
ROA(3y)11.5%
ROA(5y)8.02%
ROE(3y)23.08%
ROE(5y)14.87%
ROIC(3y)14.93%
ROIC(5y)19.59%
REPX Yearly ROA, ROE, ROICREPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

  • REPX has a better Profit Margin (41.03%) than 92.82% of its industry peers.
  • In the last couple of years the Profit Margin of REPX has grown nicely.
  • Looking at the Operating Margin, with a value of 36.04%, REPX belongs to the top of the industry, outperforming 84.21% of the companies in the same industry.
  • In the last couple of years the Operating Margin of REPX has declined.
  • REPX has a better Gross Margin (70.26%) than 78.95% of its industry peers.
  • In the last couple of years the Gross Margin of REPX has declined.
Industry RankSector Rank
OM 36.04%
PM (TTM) 41.03%
GM 70.26%
OM growth 3Y-18.41%
OM growth 5YN/A
PM growth 3Y3.81%
PM growth 5YN/A
GM growth 3Y-5.75%
GM growth 5YN/A
REPX Yearly Profit, Operating, Gross MarginsREPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

3

2. REPX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so REPX is still creating some value.
  • REPX has more shares outstanding than it did 1 year ago.
  • REPX has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for REPX has been reduced compared to a year ago.
REPX Yearly Shares OutstandingREPX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
REPX Yearly Total Debt VS Total AssetsREPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • An Altman-Z score of 1.96 indicates that REPX is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • REPX has a Altman-Z score of 1.96. This is in the better half of the industry: REPX outperforms 61.24% of its industry peers.
  • A Debt/Equity ratio of 0.36 indicates that REPX is not too dependend on debt financing.
  • REPX has a better Debt to Equity ratio (0.36) than 60.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 1.96
ROIC/WACC1.2
WACC8.9%
REPX Yearly LT Debt VS Equity VS FCFREPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M

2.3 Liquidity

  • REPX has a Current Ratio of 0.60. This is a bad value and indicates that REPX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.60, REPX is doing worse than 80.86% of the companies in the same industry.
  • REPX has a Quick Ratio of 0.60. This is a bad value and indicates that REPX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.55, REPX is doing worse than 76.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.55
REPX Yearly Current Assets VS Current LiabilitesREPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

5

3. REPX Growth Analysis

3.1 Past

  • REPX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.22%.
  • REPX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.60% yearly.
  • REPX shows a decrease in Revenue. In the last year, the revenue decreased by -4.44%.
  • Measured over the past years, REPX shows a very strong growth in Revenue. The Revenue has been growing by 164.32% on average per year.
EPS 1Y (TTM)-7.22%
EPS 3Y6.6%
EPS 5YN/A
EPS Q2Q%173.08%
Revenue 1Y (TTM)-4.44%
Revenue growth 3Y6.8%
Revenue growth 5Y164.32%
Sales Q2Q%-5.28%

3.2 Future

  • REPX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.64% yearly.
  • The Revenue is expected to grow by 8.10% on average over the next years. This is quite good.
EPS Next Y-29.84%
EPS Next 2Y6.54%
EPS Next 3YN/A
EPS Next 5Y11.64%
Revenue Next Year11.76%
Revenue Next 2Y11.44%
Revenue Next 3YN/A
Revenue Next 5Y8.1%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
REPX Yearly Revenue VS EstimatesREPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 200M 400M 600M
REPX Yearly EPS VS EstimatesREPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2029 2030 2 4 6 8

6

4. REPX Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 7.05 indicates a rather cheap valuation of REPX.
  • Compared to the rest of the industry, the Price/Earnings ratio of REPX indicates a rather cheap valuation: REPX is cheaper than 91.39% of the companies listed in the same industry.
  • REPX is valuated cheaply when we compare the Price/Earnings ratio to 24.88, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 10.05, which indicates a very decent valuation of REPX.
  • 87.56% of the companies in the same industry are more expensive than REPX, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, REPX is valued rather cheaply.
Industry RankSector Rank
PE 7.05
Fwd PE 10.05
REPX Price Earnings VS Forward Price EarningsREPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of REPX indicates a rather cheap valuation: REPX is cheaper than 89.95% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.4
REPX Per share dataREPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The decent profitability rating of REPX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.54%
EPS Next 3YN/A

6

5. REPX Dividend Analysis

5.1 Amount

  • REPX has a Yearly Dividend Yield of 4.27%, which is a nice return.
  • Compared to an average industry Dividend Yield of 3.24, REPX pays a bit more dividend than its industry peers.
  • REPX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 4.27%

5.2 History

  • REPX has been paying a dividend for over 5 years, so it has already some track record.
  • REPX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
REPX Yearly Dividends per shareREPX Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 20.72% of the earnings are spent on dividend by REPX. This is a low number and sustainable payout ratio.
DP20.72%
EPS Next 2Y6.54%
EPS Next 3YN/A
REPX Yearly Income VS Free CF VS DividendREPX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M
REPX Dividend Payout.REPX Dividend Payout, showing the Payout Ratio.REPX Dividend Payout.PayoutRetained Earnings

REPX Fundamentals: All Metrics, Ratios and Statistics

RILEY EXPLORATION PERMIAN IN

NYSEARCA:REPX (3/27/2026, 8:04:00 PM)

After market: 37.17 0 (0%)

37.17

-0.28 (-0.75%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)03-04
Earnings (Next)05-05
Inst Owners48.89%
Inst Owner Change-1.65%
Ins Owners4.54%
Ins Owner Change-39.1%
Market Cap801.76M
Revenue(TTM)391.98M
Net Income(TTM)160.84M
Analysts84
Price Target52.36 (40.87%)
Short Float %5.09%
Short Ratio2.46
Dividend
Industry RankSector Rank
Dividend Yield 4.27%
Yearly Dividend1.54
Dividend Growth(5Y)N/A
DP20.72%
Div Incr Years3
Div Non Decr Years3
Ex-Date01-22
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.55%
Min EPS beat(2)-23.94%
Max EPS beat(2)31.03%
EPS beat(4)2
Avg EPS beat(4)16.79%
Min EPS beat(4)-23.94%
Max EPS beat(4)75.15%
EPS beat(8)3
Avg EPS beat(8)1.72%
EPS beat(12)5
Avg EPS beat(12)-2.85%
EPS beat(16)7
Avg EPS beat(16)-5.72%
Revenue beat(2)1
Avg Revenue beat(2)-4.59%
Min Revenue beat(2)-11.81%
Max Revenue beat(2)2.63%
Revenue beat(4)1
Avg Revenue beat(4)-4.19%
Min Revenue beat(4)-11.81%
Max Revenue beat(4)2.63%
Revenue beat(8)2
Avg Revenue beat(8)-2.85%
Revenue beat(12)6
Avg Revenue beat(12)0.03%
Revenue beat(16)10
Avg Revenue beat(16)32.78%
PT rev (1m)-3.14%
PT rev (3m)-3.14%
EPS NQ rev (1m)43.18%
EPS NQ rev (3m)6.73%
EPS NY rev (1m)-16.09%
EPS NY rev (3m)-27.64%
Revenue NQ rev (1m)18.01%
Revenue NQ rev (3m)19.11%
Revenue NY rev (1m)-1.36%
Revenue NY rev (3m)-0.05%
Valuation
Industry RankSector Rank
PE 7.05
Fwd PE 10.05
P/S 2.05
P/FCF N/A
P/OCF 3.77
P/B 1.26
P/tB 1.26
EV/EBITDA 4.4
EPS(TTM)5.27
EY14.18%
EPS(NY)3.7
Fwd EY9.95%
FCF(TTM)-1.69
FCFYN/A
OCF(TTM)9.85
OCFY26.51%
SpS18.17
BVpS29.4
TBVpS29.4
PEG (NY)N/A
PEG (5Y)N/A
Graham Number59.05
Profitability
Industry RankSector Rank
ROA 13.75%
ROE 25.36%
ROCE 13.95%
ROIC 10.67%
ROICexc 10.86%
ROICexgc 10.86%
OM 36.04%
PM (TTM) 41.03%
GM 70.26%
FCFM N/A
ROA(3y)11.5%
ROA(5y)8.02%
ROE(3y)23.08%
ROE(5y)14.87%
ROIC(3y)14.93%
ROIC(5y)19.59%
ROICexc(3y)15.18%
ROICexc(5y)20.17%
ROICexgc(3y)15.18%
ROICexgc(5y)20.17%
ROCE(3y)19.52%
ROCE(5y)25.61%
ROICexgc growth 3Y-34.34%
ROICexgc growth 5YN/A
ROICexc growth 3Y-34.34%
ROICexc growth 5YN/A
OM growth 3Y-18.41%
OM growth 5YN/A
PM growth 3Y3.81%
PM growth 5YN/A
GM growth 3Y-5.75%
GM growth 5YN/A
F-Score7
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA 0.97
Cap/Depr 267.25%
Cap/Sales 63.53%
Interest Coverage 5.01
Cash Conversion 90.65%
Profit Quality N/A
Current Ratio 0.6
Quick Ratio 0.55
Altman-Z 1.96
F-Score7
WACC8.9%
ROIC/WACC1.2
Cap/Depr(3y)385.67%
Cap/Depr(5y)357.78%
Cap/Sales(3y)73.15%
Cap/Sales(5y)59.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.22%
EPS 3Y6.6%
EPS 5YN/A
EPS Q2Q%173.08%
EPS Next Y-29.84%
EPS Next 2Y6.54%
EPS Next 3YN/A
EPS Next 5Y11.64%
Revenue 1Y (TTM)-4.44%
Revenue growth 3Y6.8%
Revenue growth 5Y164.32%
Sales Q2Q%-5.28%
Revenue Next Year11.76%
Revenue Next 2Y11.44%
Revenue Next 3YN/A
Revenue Next 5Y8.1%
EBIT growth 1Y-28.19%
EBIT growth 3Y-12.86%
EBIT growth 5YN/A
EBIT Next Year93.06%
EBIT Next 3YN/A
EBIT Next 5Y25.02%
FCF growth 1Y-131.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.7%
OCF growth 3Y7.67%
OCF growth 5YN/A

RILEY EXPLORATION PERMIAN IN / REPX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for RILEY EXPLORATION PERMIAN IN?

ChartMill assigns a fundamental rating of 5 / 10 to REPX.


Can you provide the valuation status for RILEY EXPLORATION PERMIAN IN?

ChartMill assigns a valuation rating of 6 / 10 to RILEY EXPLORATION PERMIAN IN (REPX). This can be considered as Fairly Valued.


Can you provide the profitability details for RILEY EXPLORATION PERMIAN IN?

RILEY EXPLORATION PERMIAN IN (REPX) has a profitability rating of 7 / 10.


What are the PE and PB ratios of RILEY EXPLORATION PERMIAN IN (REPX) stock?

The Price/Earnings (PE) ratio for RILEY EXPLORATION PERMIAN IN (REPX) is 7.05 and the Price/Book (PB) ratio is 1.26.


Can you provide the financial health for REPX stock?

The financial health rating of RILEY EXPLORATION PERMIAN IN (REPX) is 3 / 10.